4.8 Article

Layer-by-Layer Assembled Antisense DNA Microsponge Particles for Efficient Delivery of Cancer Therapeutics

期刊

ACS NANO
卷 8, 期 10, 页码 9767-9780

出版社

AMER CHEMICAL SOC
DOI: 10.1021/nn502596b

关键词

DNA nanotechnology; layer-by-layer; cancer; multifunctionality; antisense therapy; DNA oligonucleotide DNA delivery

资金

  1. DoD OCRP Teal Innovator Award [OC120504]
  2. Koch Institute Core Grant from the NCI [P30-CA14051]
  3. National Science Foundation [DMR-0819762]
  4. National Sciences and Engineering Research Council (NSERC)
  5. NIH [1F32EB017614-01]
  6. National Science Foundation Graduate Research Fellowship (NSF GRF)
  7. CDMRP [OC120504, 542483] Funding Source: Federal RePORTER

向作者/读者索取更多资源

Antisense oligonucleotides can be employed as a potential approach to effectively treat cancer. However, the inherent instability and inefficient systemic delivery methods for antisense therapeutics remain major challenges to their clinical application. Here, we present a polymerized oligonucleotides (ODNs) that self-assemble during their formation through an enzymatic elongation method (rolling circle replication) to generate a composite nucleic acid/magnesium pyrophosphate sponge-like microstructure, or DNA microsponge, yielding high molecular weight nucleic acid product. In addition, this densely packed ODN microsponge structure can be further condensed to generate polyelectrolyte complexes with a favorable size for cellular uptake by displacing magnesium pyrophosphate crystals from the microsponge structure. Additional layers are applied to generate a blood-stable and multifunctional nanoparticle via the layer-by-layer (LbL) assembly technique. By taking advantage of DNA nanotechnology and LbL assembly, functionalized DNA nanostructures were utilized to provide extremely high numbers of repeated ODN copies for efficient antisense therapy. Moreover, we show that this formulation significantly improves nucleic acid drug/carrier stability during in vivo biodistribution. These polymeric ODN systems can be designed to serve as a potent means of delivering stable and large quantities of ODN therapeutics systemically for cancer treatment to tumor cells at significantly lower toxicity than traditional synthetic vectors, thus enabling a therapeutic window suitable for clinical translation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据